2% foam, 50 g and 100 g
Indications and Usage:
Extina Foam is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older.
Side Effects and Contraindications:
The most common adverse reactions to Extina Foam observed in clinical trials (incidence > 1%) were application-site burning (10%) and application-site reaction(6%). There are no contraindications to the use of Extina Foam. Extina (ketoconazole) Foam, 2% is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older. Safety and efficacy of Extina Foam for treatment of fungal infections have not been established. Extina Foam may result in contact sensitization, including photoallergenicity. Extina Foam is not for ophthalmic, oral, and intravaginal use.
Stiefel, a GSK Company